BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu W, Shi L, Sawhney M, Gu X, Chen Y. Evidence for the effectiveness of anti-hypertensive medicines included on the Chinese National Reimbursement Drug List. BMC Health Serv Res 2019;19:112. [PMID: 30744609 DOI: 10.1186/s12913-019-3937-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang C, Ma E, Liu B, Wu B, Gu Z, Lin H. Framework Development for Clinical Comprehensive Evaluation of Drugs–a Study Protocol Using the Delphi Method and Analytic Hierarchy Process. Front Pharmacol 2022;13:869319. [DOI: 10.3389/fphar.2022.869319] [Reference Citation Analysis]
2 Zhang Y, Wushouer H, Han S, Fu M, Guan X, Shi L, Wagner A. The impacts of government reimbursement negotiation on targeted anticancer medication price, volume and spending in China. BMJ Glob Health 2021;6:e006196. [PMID: 34266848 DOI: 10.1136/bmjgh-2021-006196] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]